Inhibition of Talin2 dedifferentiates myofibroblasts and reverses lung and kidney fibrosis
Abstract Fibrosis is involved in 45% of deaths in the United States, and no treatment exists to reverse progression of the disease. To find novel targets for fibrosis therapeutics, we developed a model for the differentiation of monocytes to myofibroblasts that allowed us to screen for proteins invo...
Saved in:
| Main Authors: | Michael J. V. White, Melis Ozkan, Jorge Emiliano Gomez Medellin, Ani Solanki, Jeffrey A. Hubbell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-00939-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Engineering IL-10 and rapamycin to bind collagen leads to improved anti fibrotic efficacy in lung and kidney fibrosis
by: Michael J. V. White, et al.
Published: (2025-04-01) -
Revisiting pulmonary fibrosis: inflammatory dynamics of the lipofibroblast-to-inflammatory lipofibroblast-to-activated myofibroblast reversible switch
by: Georgios-Dimitrios Panagiotidis, et al.
Published: (2025-06-01) -
Epidermal stem cell derived exosomes-induced dedifferentiation of myofibroblasts inhibits scarring via the miR-203a-3p/PIK3CA axis
by: Shixin Zhao, et al.
Published: (2025-01-01) -
From benign appearance to malignant truth: a case report of mesenteric dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features
by: Simon Schallenberg, et al.
Published: (2025-04-01) -
Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis
by: Imre Noth, et al.
Published: (2023-07-01)